Noxopharm Limited Email Formats

Biotechnology Research • Sydney, New South Wales, Australia • 11-20 Employees

Noxopharm Limited Email Formats

Noxopharm Limited uses 3 email formats. The most common is {first initial}.{last name} (e.g., j.doe@noxopharm.com), used 66.7% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@noxopharm.com	66.7%
{first initial}	j@noxopharm.com	16.7%
{first name}.{last name}	john.doe@noxopharm.com	16.7%

Key Contact at Noxopharm Limited

Julian Elliott

Corporate Communications Director

Company overview

Headquarters	Suite 71, 159 Ridgecrop Drive, Sydney - Castle Hill, New South Wales 2154, AU
Phone number	+61291442223
Website	noxopharm.com
NAICS	541714
SIC	283
Keywords	Biotechnology, Pharmaceutical, Oncology, Drug Development, RNA, Preclinical Research, Small Molecule, Psoriasis, Autoimmune Disease, Lupus, Nucleic Acids, Chronic Inflammation, Oligonucleotides, Inflammatory Disease, Mrna Therapeutics, Mrna Vaccines, Tlr7, Tbk1, Tlr8, Rig-I
Founded	2015
Employees	11-20
Socials

About Noxopharm Limited

Noxopharm Limited (ASX:NOX) is a clinical-stage Australian biotech company discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to improve the safety profile of a wide range of mRNA medicines. The company utilises specialist in-house capabilities and strategic partnerships with leading researchers to build a growing pipeline of new proprietary drugs based on two technology platforms – Sofra™ (inflammation, autoimmunity, mRNA drug enhancement, and oncology) and Chroma™ (oncology). Noxopharm’s management team has extensive and highly relevant experience spanning a wide range of activities, including over 100 years of combined pharma experience, 20+ drug launches in numerous therapeutic areas, involvement in more than 100 clinical trials, 60+ years of academic research and 150+ peer-reviewed publications. A core strength at all levels of the company is a focus on external collaborations, whether with research institutions and academia, suppliers or industry partners both in Australia and overseas. These relationships enable Noxopharm and its network to efficiently develop new proprietary assets that have demonstrable commercial potential. Likes and shares are not endorsements

Employees by Management Level

Total employees: 11-20

Seniority

Employees

C-Suite

Manager

Director

Employees by Department

Noxopharm Limited has 7 employees across 6 departments.

Departments

Number of employees

Funding Data

Explore Noxopharm Limited's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2021-01-03	14	$17,100,000

Funding Insights

$17,100,000

Total funding amount

$17,100,000

Most recent funding amount

Number of funding rounds

Noxopharm Limited Tech Stack

Discover the technologies and tools that power Noxopharm Limited's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

CDN

Amazon Web Services

PaaS

reCAPTCHA

Security

jQuery

JavaScript libraries

Google Tag Manager

Tag managers

Slick

JavaScript libraries

HSTS

Security

FancyBox

JavaScript libraries

Open Graph

Miscellaneous

Font Awesome

Font scripts

ZURB Foundation

UI frameworks

Google Analytics

Analytics

Frequently asked questions

Noxopharm Limited is located in Sydney, New South Wales, AU.

You can reach Noxopharm Limited at +61291442223.

Noxopharm Limited was founded in 2015, making it 11 years old. The company has established itself as a significant player in its industry over this time.

Noxopharm Limited has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Noxopharm Limited has raised a total of $17,100,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Noxopharm Limited

Julian Elliott

Corporate Communications Director

4.8

40,000 users